Summary

Cardiac resynchronization therapy (CRT) continues to benefit many patients with heart failure (HF), reducing their symptoms and enhancing clinical outcomes and quality of life. This article discusses a series of sessions which covered current perspectives on CRT, including techniques to approach the left ventricle (LV) and optimize lead placement, as well as data from clinical trials that favor the use of triventricular (TriV) pacing. Specific topics include device implantation and optimal lead placement, improving CRT response and optimizing LV site positioning, and the the Dual-Site LV Pacing in CRT Non Responders: Multicenter Randomized Trial [V3; NCT01059175; Bordachar P et al. J Card Fail 2010].